Horizon Technology Finance Corp  

(Public, NASDAQ:HRZN)   Watch this stock  
Find more results for Dan Michaud
+0.01 (0.08%)
Apr 16 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 13.10 - 13.22
52 week 12.17 - 14.76
Open 13.20
Vol / Avg. 78,918.00/135,749.00
Mkt cap 126.63M
P/E 35.86
Div/yield 0.12/10.48
EPS 0.37
Shares 9.62M
Beta 0.36
Inst. own 25%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -530.71% 201.73%
Operating margin -258.59% -590.51%
EBITD margin - -590.51%
Return on average assets -6.63% 1.39%
Return on average equity -12.96% 2.50%
CDP Score - -


United States - Map
+1-860-6768654 (Phone)
+1-860-6768655 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Horizon Technology Finance Corporation is a closed-end, non-diversified management investment company. The Company�s investment objective is to generate current income from the loans it makes and capital appreciation from the warrants it receives when making such loans. It makes secured loans (venture loans) to companies backed by established venture capital and private equity firms in its target industries (venture lending). Horizon Technology Finance Management LLC is the advisor of the Company. In December 2013, the Company announced in connection with the sale of substantially all of the assets of ACT Biotech, Inc, the Company has successfully settled its investment in ACT Biotech, Inc.

Officers and directors

Robert D. Pomeroy Jr. Chairman of the Board, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Gerald A. Michaud President, Director
Age: 60
Bio & Compensation  - Reuters
Christopher M. Mathieu Chief Financial Officer, Senior Vice President, Treasurer
Age: 47
Bio & Compensation  - Reuters
John C. Bombara Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Age: 49
Bio & Compensation  - Reuters
Dan S. Devorsetz Senior Vice President, Chief Credit Officer
Age: 42
Bio & Compensation  - Reuters
Christopher B. Woodward Lead Independent Director
Age: 65
Bio & Compensation  - Reuters
James J. Bottiglieri Independent Director
Age: 57
Bio & Compensation  - Reuters
Edmund V. Mahoney Independent Director
Age: 62
Bio & Compensation  - Reuters
Elaine A. Sarsynski Independent Director
Age: 57
Bio & Compensation  - Reuters